Clinical Study on the Treatment of Severe Mycoplasma Pneumonia in Children with Yindai Tang Combined with Collapse Stain Therapy
Not Applicable
Recruiting
- Conditions
- Severe Mycoplasma pneumoniae pneumonia in children
- Registration Number
- ITMCTR2024000073
- Lead Sponsor
- Beijing Children's Hospital Affiliated to Capital Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Meets the diagnostic criteria for Western medicine severe Mycoplasma pneumonia and traditional Chinese medicine phlegm heat closed lung syndrome, aged 5-18 years old; The family members of the affected child are fully aware of the significance of this study and are willing to cooperate with its implementation.
Exclusion Criteria
Individuals with serious complications such as toxic encephalopathy, heart failure, and respiratory failure; Patients with combined immune system, blood system, nervous system diseases, congenital genetic metabolic diseases, and tumor diseases; Individuals who are allergic to the drugs used in this study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficiency;
- Secondary Outcome Measures
Name Time Method Pulmonary function;Absorption of lesions in chest imaging;Time for fever relief, cough and asthma relief, and disappearance of lung rales;Liver and kidney function, CRP, LDH, IL-1 ß\ IL-6, D-dimer levels;